ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
RCPI was delisted on the 4th of November, 2015.
59 hedge funds and large institutions have $3.54M invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 5 closing their positions.
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
30% more capital invested
Capital invested by funds: $2.72M → $3.54M (+$818K)
7% more funds holding
Funds holding: 55 → 59 (+4)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
57% less call options, than puts
Call options by funds: $3K | Put options by funds: $7K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$741K |
| 2 |
TC
Talkot Capital
Sausalito,
California
|
+$131K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$66.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$21.1K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$9.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$99.1K |
| 2 |
GCM
Goldman Capital Management
New York
|
-$93.1K |
| 3 |
Millennium Management
New York
|
-$73.6K |
| 4 |
Comerica Bank
Dallas,
Texas
|
-$31.5K |
| 5 |
LCM
Lucas Capital Management
Red Bank,
New Jersey
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BW
51
Bison Wealth
Atlanta,
Georgia
| – | -$2K | -504 | Closed |
|
52
Citigroup
New York
| – | +$16 | +4 | New |
|
53
Creative Planning
Overland Park,
Kansas
| – | +$79 | +20 | +13% |
|
|
GWM
54
Gupta Wealth Management
San Diego,
California
| – | +$94 | +24 | New |
|
|
MFS
55
MSI Financial Services
Springfield,
Massachusetts
| – | +$157 | +40 | New |
|
56
Simplex Trading
Chicago,
Illinois
| – | +$283 | +72 | New |
|
RCPI Hedge Fund Activity: Q1 2015 in Review
59 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q1 2015, worth a combined $3.54M — up 30% from $2.72M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new RCPI positions and 5 closed out — a net gain of 5 holders — while 9 added to existing stakes and 13 trimmed.
The largest buyer was Ameriprise, opening a new position worth an estimated $741K. The largest seller was Susquehanna International Group, cutting an estimated $99.1K.
- 59 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q1 2015, up from 55 in Q4 2014.
- Funds reported $3.54M of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q1 2015, up 30% quarter-over-quarter.
- 10 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q1 2015 and 5 closed out, a net change of +5 holders.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2015 was Ameriprise, an estimated $741K added.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) seller in Q1 2015 was Susquehanna International Group, an estimated $99.1K sold.
Based on aggregated 13F filings for Q1 2015.